Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Evelo Biosciences, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 46 | 41 | −5 |
| Shares | 85.5M | 86.1M | +631.7K (+0.7%) |
| Value | $180.4M | $180.0M | −$383.3K (−0.2%) |
New holders (6)
Institutions that held Evelo Biosciences, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 105,300 | $220.0K | 0.01% |
| Susquehanna International Group, LLP | 17,973 | $38.0K | 0.00% |
| Barclays PLC | 3,002 | $6.00K | 0.00% |
| UBS Group AG | 2,612 | $5.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,011 | $2.00K | 0.00% |
| Royal Bank of Canada | 144 | $0 | 0.00% |
Sold out (11)
Institutions that held Evelo Biosciences, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Standard Life Aberdeen plc | 342,465 | $716.0K |
| Norges Bank | 294,242 | $620.9K |
| EcoR1 Capital, LLC | 200,417 | $423.0K |
| Citadel Advisors LLC | 107,423 | $226.0K |
| AE Wealth Management LLC | 56,029 | $118.0K |
| HRT Financial LP | 28,252 | $59.0K |
| Jump Financial, LLC | 26,500 | $56.0K |
| Two Sigma Investments, LP | 26,116 | $55.0K |
| Two Sigma Advisers, LP | 26,300 | $55.0K |
| D. E. Shaw & Co., Inc. | 19,205 | $41.0K |
| New York State Common Retirement Fund | 265 | $1.00K |